Icahn renews offer to buy Mylan

Carl Icahn is making a new bid to buy Mylan Laboratories, this time offering more than $5 billion for the drug company. He made his first bid for Mylan last fall as he fought against a proposed buyout of King Pharmaceutical. That deal fell apart earlier this year.

- read this story from the Boston Globe for more on the buyout offer

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.